Strategy to Improve Adherence of Roflumilast
NCT02018432
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG:
Roflumilast escalation dosage
DRUG:
Roflumilast conventional dosage
Sponsor
Asan Medical Center